301 related articles for article (PubMed ID: 33876782)
1. Clinical Profile and Short-Term Outcome of Children With SARS-CoV-2 Related Multisystem Inflammatory Syndrome (MIS-C) Treated With Pulse Methylprednisolone.
Sugunan S; Bindusha S; Geetha S; Niyas HR; Kumar AS
Indian Pediatr; 2021 Aug; 58(8):718-722. PubMed ID: 33876782
[TBL] [Abstract][Full Text] [Related]
2. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.
Ouldali N; Toubiana J; Antona D; Javouhey E; Madhi F; Lorrot M; Léger PL; Galeotti C; Claude C; Wiedemann A; Lachaume N; Ovaert C; Dumortier M; Kahn JE; Mandelcwajg A; Percheron L; Biot B; Bordet J; Girardin ML; Yang DD; Grimaud M; Oualha M; Allali S; Bajolle F; Beyler C; Meinzer U; Levy M; Paulet AM; Levy C; Cohen R; Belot A; Angoulvant F;
JAMA; 2021 Mar; 325(9):855-864. PubMed ID: 33523115
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of 11 cases multisystem inflammatory syndrome associated with SARS-CoV-2 Omicron variant infection in children].
Zhang HS; Chang XT; Wu PH; Song DY; Ge G; Ding W; Hu ZW; Wang GF; Jiang YW; Ye LP
Zhonghua Er Ke Za Zhi; 2024 Jan; 62(1):55-59. PubMed ID: 38154978
[No Abstract] [Full Text] [Related]
4. Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group
Lancet Child Adolesc Health; 2024 Mar; 8(3):190-200. PubMed ID: 38272046
[TBL] [Abstract][Full Text] [Related]
5. A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children with the multisystem inflammatory syndrome.
Devrim İ; Böncüoğlu E; Kıymet E; Şahinkaya Ş; Çelebi MY; Cem E; Düzgöl M; Arıkan KÖ; Kara AA; Besin D; Vuran G; Seven P; Meşe T; Ağın H; Bayram N
Pediatr Rheumatol Online J; 2022 Aug; 20(1):69. PubMed ID: 35987681
[TBL] [Abstract][Full Text] [Related]
6. Clinico-Laboratory Profile, Intensive Care Needs and Short-Term Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience during First and Second Waves from North India.
Angurana SK; Kumar V; Nallasamy K; Kumar MR; Naganur S; Kumar M; Goyal K; Ghosh A; Bansal A; Jayashree M
J Trop Pediatr; 2022 Aug; 68(5):. PubMed ID: 36048462
[TBL] [Abstract][Full Text] [Related]
7. Multisystem Inflammatory Syndrome in Children (MIS-C) Related to SARS-CoV-2 and 1-Year Follow-up.
Kapoor R; Chandra T; Singh CP; Singh R; Pandey I
Indian J Pediatr; 2023 Oct; 90(10):1008-1012. PubMed ID: 36482236
[TBL] [Abstract][Full Text] [Related]
8. Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals.
Harthan AA; Nadiger M; McGarvey JS; Hanson K; Gharpure VP; Bjornstad EC; Chiotos K; Miller AS; Reikoff RA; Gajic O; Kumar V; Walkey AJ; Kashyap R; Tripathi S;
Pharmacotherapy; 2022 Jul; 42(7):529-539. PubMed ID: 35661394
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular injury and clinical features of multisystem inflammatory syndrome in children (MIS-C) related to Covid-19 in Vietnam.
Phung NTN; Tran TT; Nguyen TH; Nguyen TH; Nguyen TMT
Pediatr Neonatol; 2022 Nov; 63(6):569-574. PubMed ID: 35871994
[TBL] [Abstract][Full Text] [Related]
10. Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial.
Welzel T; Atkinson A; Schöbi N; Andre MC; Bailey DGN; Blanchard-Rohner G; Buettcher M; Grazioli S; Koehler H; Perez MH; Trück J; Vanoni F; Zimmermann P; Sanchez C; Bielicki JA; Schlapbach LJ;
Lancet Child Adolesc Health; 2023 Apr; 7(4):238-248. PubMed ID: 36746174
[TBL] [Abstract][Full Text] [Related]
11. Ten-month follow-up of patients with covid-19 temporally related multi-system inflammatory syndrome in children: the experience of the children hospital of Palermo.
Maggio MC; Giordano S; Failla MC; Campione MG; Alaimo A; Corsello G
Ital J Pediatr; 2023 Mar; 49(1):37. PubMed ID: 36959663
[TBL] [Abstract][Full Text] [Related]
12. Management skin manifestation of multisystem inflammatory syndrome associated with SARS-CoV-2.
Bayram YE; Yildiz-Sevgi D; Yavuz A; Cancetin M; Gurler MY
Virol J; 2022 Jan; 19(1):9. PubMed ID: 34991644
[TBL] [Abstract][Full Text] [Related]
13. Recent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage.
Vukomanovic V; Krasic S; Prijic S; Ninic S; Popovic S; Petrovic G; Ristic S; Simic R; Cerovic I; Nesic D
Pediatr Infect Dis J; 2021 Nov; 40(11):e390-e394. PubMed ID: 34260481
[TBL] [Abstract][Full Text] [Related]
14. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R;
Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303
[TBL] [Abstract][Full Text] [Related]
15. Intensive Care Needs and Short-Term Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience from North India.
Angurana SK; Awasthi P; Thakur A; Randhawa MS; Nallasamy K; Kumar MR; Naganur S; Kumar M; Goyal K; Ghosh A; Bansal A; Jayashree M
J Trop Pediatr; 2021 Jul; 67(3):. PubMed ID: 34170328
[TBL] [Abstract][Full Text] [Related]
16. Multiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescent.
Bastug A; Aslaner H; Aybar Bilir Y; Kemirtlek N; Gursoy FM; Bastug S; Bodur H
Rheumatol Int; 2021 May; 41(5):993-1008. PubMed ID: 33742229
[TBL] [Abstract][Full Text] [Related]
17. A 7-Year-Old Boy and a 14-Year-Old Girl Initially Diagnosed with Toxic Shock Syndrome and Tested Positive for SARS-CoV-2 Infection, Supporting a Diagnosis of Multisystem Inflammatory Syndrome in Children (MIS-C).
Giordano S; Failla MC; Li Cavoli MG; Romano D; Vanella V; Caruso C; Chillura I; Maggio MC
Am J Case Rep; 2021 Oct; 22():e931570. PubMed ID: 34635631
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Multisystem Inflammatory Syndrome in Children.
McArdle AJ; Vito O; Patel H; Seaby EG; Shah P; Wilson C; Broderick C; Nijman R; Tremoulet AH; Munblit D; Ulloa-Gutierrez R; Carter MJ; De T; Hoggart C; Whittaker E; Herberg JA; Kaforou M; Cunnington AJ; Levin M;
N Engl J Med; 2021 Jul; 385(1):11-22. PubMed ID: 34133854
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of multisystem inflammatory syndrome in children temporally related to COVID-19: a longitudinal study.
Bagri NK; Deepak RK; Meena S; Gupta SK; Prakash S; Setlur K; Satapathy J; Chopra K; Upadhyay AD; Ramakrishnan S; Lodha R; Dar L; Trikha A; Kabra SK
Rheumatol Int; 2022 Mar; 42(3):477-484. PubMed ID: 34665296
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study.
Dizon BLP; Redmond C; Gotschlich EC; Sule S; Ronis T; Vazzana KM; Sherman MA; Connor R; Bosk A; Dham N; Harahsheh AS; Wells E; DeBiasi R; Srinivasalu H
Pediatr Rheumatol Online J; 2023 Jul; 21(1):76. PubMed ID: 37525200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
